Hyung-Joo Oh - Search Results

Year	Number of Results
2016	4
2017	1
2020	1
2021	3
2022	5
2023	10
2024	1

1

Korean Real-World Data on Patients With Unresectable Stage III NSCLC Treated With Durvalumab After Chemoradiotherapy: PACIFIC-KR.

Park CK, Oh HJ, Kim YC, Kim YH, Ahn SJ, Jeong WG, Lee JY, Lee JC, Choi CM, Ji W, Song SY, Choi J, Lee SY, Kim H, Lee SY, Park J, Yoon SH, Joo JH, Oh IJ. Park CK, et al. Among authors: oh hj. J Thorac Oncol. 2023 Aug;18(8):1042-1054. doi: 10.1016/j.jtho.2023.04.008. Epub 2023 Apr 20. J Thorac Oncol. 2023. PMID: 37085032 Free article.

2

Serum KL-6 levels predict the occurrence and severity of treatment-related interstitial lung disease in lung cancer.

Park HK, Yoon CS, Na YO, Lee JK, Oh HJ, Park HY, Kho BG, Kim TO, Shin HJ, Kwon YS, Oh IJ, Kim YI, Lim SC, Kim YC, Park CK. Park HK, et al. Among authors: oh hj. Sci Rep. 2023 Oct 23;13(1):18126. doi: 10.1038/s41598-023-45170-8. Sci Rep. 2023. PMID: 37872370 Free PMC article.

3

Genetic Alterations and Risk Factors for Recurrence in Patients with Non-Small Cell Lung Cancer Who Underwent Complete Surgical Resection.

Park HK, Choi YD, Yun JS, Song SY, Na KJ, Yoon JY, Yoon CS, Oh HJ, Kim YC, Oh IJ. Park HK, et al. Among authors: oh hj. Cancers (Basel). 2023 Nov 30;15(23):5679. doi: 10.3390/cancers15235679. Cancers (Basel). 2023. PMID: 38067382 Free PMC article.

4

Nicotinamide in Combination with EGFR-TKIs for the Treatment of Stage IV Lung Adenocarcinoma with EGFR Mutations: A Randomized Double-Blind (Phase IIb) Trial.

Oh HJ, Bae SC, Oh IJ, Park CK, Jung KM, Kim DM, Lee JW, Kang CK, Park IY, Kim YC. Oh HJ, et al. Clin Cancer Res. 2024 Apr 15;30(8):1478-1487. doi: 10.1158/1078-0432.CCR-23-3059. Clin Cancer Res. 2024. PMID: 38593249 Clinical Trial.

5

Usefulness of Mycobacterium tuberculosis-polymerase chain reaction with bronchial washing samples in predicting discontinuation of airborne infection isolation in patients hospitalized with suspected pulmonary tuberculosis.

Kim TO, Na YO, Park HK, Lee JK, Oh HJ, Kho BG, Park HY, Kwon YS, Kim YI, Lim SC, Shin HJ. Kim TO, et al. Among authors: oh hj. PLoS One. 2022 Dec 30;17(12):e0279256. doi: 10.1371/journal.pone.0279256. eCollection 2022. PLoS One. 2022. PMID: 36584035 Free PMC article. Review.

6

Risk factors for cerebral complications in patients with pulmonary arteriovenous malformations: A multicenter retrospective cohort study.

Na YO, Park HK, Lee JK, Kho BG, Kim TO, Shin HJ, Kwon YS, Kim YI, Lim SC, Oh HJ, Park CK, Oh IJ, Kim YC, Park HY. Na YO, et al. Among authors: oh hj. PLoS One. 2022 Dec 1;17(12):e0278610. doi: 10.1371/journal.pone.0278610. eCollection 2022. PLoS One. 2022. PMID: 36454973 Free PMC article.

7

Life-threatening Mycobacterium intracellulare pleuritis in an immunocompetent host: Case reports.

Kho BG, Na YO, Park HK, Lee JK, Oh HJ, Park HY, Kim TO, Shin HJ, Kwon YS, Kim YI, Lim SC. Kho BG, et al. Among authors: oh hj. Medicine (Baltimore). 2021 Dec 23;100(51):e28342. doi: 10.1097/MD.0000000000028342. Medicine (Baltimore). 2021. PMID: 34941139 Free PMC article.

8

Intracranial Efficacy of Systemic Therapy in Patients with Asymptomatic Brain Metastases from Lung Cancer.

Sun MG, Park SJ, Kim YJ, Moon KS, Kim IY, Jung S, Oh HJ, Oh IJ, Jung TY. Sun MG, et al. Among authors: oh hj. J Clin Med. 2023 Jun 27;12(13):4307. doi: 10.3390/jcm12134307. J Clin Med. 2023. PMID: 37445347 Free PMC article.

9

Risk factors and clinical outcomes associated with acquired hypofibrinogenemia in patients administered hemocoagulase batroxobin for hemoptysis.

Lee JK, Yoon CS, Na YO, Park HK, Oh HJ, Kho BG, Park HY, Kim TO, Shin HJ, Kwon YS, Kim YI, Lim SC. Lee JK, et al. Among authors: oh hj. J Thorac Dis. 2023 Jan 31;15(1):65-76. doi: 10.21037/jtd-22-717. Epub 2022 Dec 9. J Thorac Dis. 2023. PMID: 36794140 Free PMC article.

10

A method for early diagnosis of lung cancer from tumor originated DNA fragments using plasma cfDNA methylome and fragmentome profiles.

Kim YJ, Jeon H, Jeon S, Lee SH, Kim C, Ahn JH, Um H, Woo YJ, Jeong SH, Kim Y, Park HY, Oh HJ, Cho HJ, Bae JH, Kim JH, An S, Kang SB, Jho S, Biro O, Kis D, Kim BC, Kim Y, Kim JH, Kim BC, Bhak J, Oh IJ. Kim YJ, et al. Among authors: oh hj. Mol Cell Probes. 2022 Dec;66:101873. doi: 10.1016/j.mcp.2022.101873. Epub 2022 Nov 12. Mol Cell Probes. 2022. PMID: 36379302

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

24 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Results by year